• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌前病变:发生、发展因素及治疗

Gastric precancerous lesions:occurrence, development factors, and treatment.

作者信息

Cao Yue, Wang Dongcai, Mo Guiyun, Peng Yinghui, Li Zengzheng

机构信息

Emergency of Department, Yunnan Provincial Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, China.

Emergency Teaching and Research Department of the First Clinical School of Yunnan University of Traditional Chinese Medicine, Kunming, China.

出版信息

Front Oncol. 2023 Aug 30;13:1226652. doi: 10.3389/fonc.2023.1226652. eCollection 2023.

DOI:10.3389/fonc.2023.1226652
PMID:37719006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10499614/
Abstract

Patients with gastric precancerous lesions (GPL) have a higher risk of gastric cancer (GC). However, the transformation of GPL into GC is an ongoing process that takes several years. At present, several factors including H.Pylori (Hp), flora imbalance, inflammatory factors, genetic variations, Claudin-4, gastric stem cells, solute carrier family member 26 (SLC26A9), bile reflux, exosomes, and miR-30a plays a considerable role in the transformation of GPL into GC. Moreover, timely intervention in the event of GPL can reduce the risk of GC. In clinical practice, GPL is mainly treated with endoscopy, acid suppression therapy, Hp eradication, a cyclooxygenase-2 inhibitor, aspirin, and diet. Currently, the use of traditional Chinese medicine (TCM) or combination with western medication to remove Hp and the use of TCM to treat GPL are common in Asia, particularly China, and have also demonstrated excellent clinical efficacy. This review thoroughly discussed the combining of TCM and Western therapy for the treatment of precancerous lesions as conditions allow. Consequently, this review also focuses on the causes of the development and progression of GPL, as well as its current treatment. This may help us understand GPL and related treatment.

摘要

胃癌前病变(GPL)患者患胃癌(GC)的风险更高。然而,GPL向GC的转变是一个持续数年的过程。目前,包括幽门螺杆菌(Hp)、菌群失调、炎症因子、基因变异、Claudin-4、胃干细胞、溶质载体家族成员26(SLC26A9)、胆汁反流、外泌体和miR-30a等多种因素在GPL向GC的转变中起着相当重要的作用。此外,在GPL发生时及时干预可降低GC的风险。在临床实践中,GPL主要通过内镜检查、抑酸治疗、根除Hp、使用环氧化酶-2抑制剂、阿司匹林和饮食进行治疗。目前,在亚洲尤其是中国,使用中药(TCM)或中西医结合来根除Hp以及使用中药治疗GPL很常见,并且也已显示出优异的临床疗效。本综述在条件允许的情况下深入探讨了中西医结合治疗癌前病变的情况。因此,本综述还聚焦于GPL发生发展的原因及其当前的治疗方法。这可能有助于我们了解GPL及相关治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570c/10499614/73e8a391206e/fonc-13-1226652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570c/10499614/9a895ed19bc3/fonc-13-1226652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570c/10499614/73e8a391206e/fonc-13-1226652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570c/10499614/9a895ed19bc3/fonc-13-1226652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570c/10499614/73e8a391206e/fonc-13-1226652-g002.jpg

相似文献

1
Gastric precancerous lesions:occurrence, development factors, and treatment.胃癌前病变:发生、发展因素及治疗
Front Oncol. 2023 Aug 30;13:1226652. doi: 10.3389/fonc.2023.1226652. eCollection 2023.
2
Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review.中药对胃癌前病变向胃癌转化的作用:一项批判性综述。
World J Gastrointest Oncol. 2023 Jan 15;15(1):36-54. doi: 10.4251/wjgo.v15.i1.36.
3
Inflammatory microenvironment in gastric premalignant lesions: implication and application.胃前病变中的炎症微环境:意义与应用。
Front Immunol. 2023 Nov 15;14:1297101. doi: 10.3389/fimmu.2023.1297101. eCollection 2023.
4
The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.黄芪甲苷对 MNNG 致 GPL 大鼠胃黏膜的保护作用。
Biomed Pharmacother. 2018 Aug;104:291-299. doi: 10.1016/j.biopha.2018.04.013. Epub 2018 May 25.
5
A Systematic Review of the Mechanisms Underlying Treatment of Gastric Precancerous Lesions by Traditional Chinese Medicine.中医药治疗胃癌前病变机制的系统评价
Evid Based Complement Alternat Med. 2020 Apr 26;2020:9154738. doi: 10.1155/2020/9154738. eCollection 2020.
6
Functional gene polymorphisms and expression alteration of selected microRNAs and the risk of various gastric lesions in -related gastric diseases.功能基因多态性及特定微小RNA的表达改变与胃相关疾病中各种胃部病变的风险
Front Genet. 2023 Jan 12;13:1097543. doi: 10.3389/fgene.2022.1097543. eCollection 2022.
7
Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway.没食子酸通过抑制 Wnt/β-连环蛋白信号通路减轻胃前病变。
J Ethnopharmacol. 2023 Feb 10;302(Pt A):115885. doi: 10.1016/j.jep.2022.115885. Epub 2022 Oct 31.
8
Efficacy of traditional Chinese Medicine for gastric precancerous lesion: A meta-analysis of randomized controlled trials.中药治疗胃癌前病变的疗效:一项随机对照试验的荟萃分析。
Complement Ther Clin Pract. 2020 Feb;38:101075. doi: 10.1016/j.ctcp.2019.101075. Epub 2019 Nov 21.
9
CXCR4 is a Novel Biomarker Correlated With Malignant Transformation and Immune Infiltrates in Gastric Precancerous Lesions.CXCR4是一种与胃癌前病变的恶性转化和免疫浸润相关的新型生物标志物。
Front Mol Biosci. 2021 Oct 5;8:697993. doi: 10.3389/fmolb.2021.697993. eCollection 2021.
10
Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study.胆汁反流是胃癌前病变和胃癌的独立危险因素:一项观察性横断面研究。
J Dig Dis. 2021 May;22(5):282-290. doi: 10.1111/1751-2980.12986. Epub 2021 May 6.

引用本文的文献

1
Development and validation of a clinical model to predict low-grade intraepithelial neoplasia in chronic atrophic gastritis patients: a retrospective observational multicenter analysis.预测慢性萎缩性胃炎患者低级别上皮内瘤变的临床模型的开发与验证:一项回顾性观察性多中心分析
Front Oncol. 2025 Jun 4;15:1597099. doi: 10.3389/fonc.2025.1597099. eCollection 2025.
2
Research progress on the therapeutic effects of effective components of traditional Chinese medicine in the treatment of gastric cancer precursors through modulation of multiple signaling pathways.中药有效成分通过调控多条信号通路治疗胃癌前体病变的研究进展
Front Oncol. 2025 May 19;15:1555274. doi: 10.3389/fonc.2025.1555274. eCollection 2025.
3

本文引用的文献

1
Circulating Tumor Cells as Diagnostic Markers of Early Gastric Cancer and Gastric Precancerous Lesions.循环肿瘤细胞作为早期胃癌和胃癌前病变的诊断标志物。
Oncology. 2023;101(8):512-519. doi: 10.1159/000531323. Epub 2023 Jun 1.
2
Chinese integrated guideline on the management of gastric precancerous conditions and lesions.《中国胃癌前疾病及病变管理的综合指南》
Chin Med. 2022 Dec 14;17(1):138. doi: 10.1186/s13020-022-00677-6.
3
Cytokines help suggest aplastic anemia with pulmonary bacterial or co-fungal infection.细胞因子有助于提示伴有肺部细菌或真菌合并感染的再生障碍性贫血。
Crosstalk between bile acids and gut microbiota: a potential target for precancerous lesions of gastric cancer.
胆汁酸与肠道微生物群之间的相互作用:胃癌癌前病变的一个潜在靶点。
Front Pharmacol. 2025 Mar 13;16:1533141. doi: 10.3389/fphar.2025.1533141. eCollection 2025.
4
Gastric cancer diagnosis and prevention: Detecting precancerous at community level.胃癌的诊断与预防:在社区层面检测癌前病变
World J Gastrointest Oncol. 2025 Mar 15;17(3):100521. doi: 10.4251/wjgo.v17.i3.100521.
5
Development and validation of a nomogram for obesity and related factors to detect gastric precancerous lesions in the Chinese population: a retrospective cohort study.中国人群中用于检测胃癌前病变的肥胖及相关因素列线图的开发与验证:一项回顾性队列研究
Front Oncol. 2024 Nov 20;14:1419845. doi: 10.3389/fonc.2024.1419845. eCollection 2024.
6
Modern technology-based exploration of mechanism of traditional Chinese medicine in prevention and treatment of gastric cancer.基于现代技术探索中医药防治胃癌的机制
World J Gastrointest Oncol. 2024 Sep 15;16(9):3747-3751. doi: 10.4251/wjgo.v16.i9.3747.
7
Editorial: Antioxidants and inflammatory immune-related diseases.社论:抗氧化剂与炎症免疫相关疾病
Front Immunol. 2024 Aug 19;15:1476887. doi: 10.3389/fimmu.2024.1476887. eCollection 2024.
Sci Rep. 2022 Nov 1;12(1):18373. doi: 10.1038/s41598-022-22503-7.
4
Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management.胆汁反流性胃炎:发病机制、相关因素、癌变风险、诊断及治疗的研究进展
Gastroenterol Res Pract. 2022 Sep 12;2022:2642551. doi: 10.1155/2022/2642551. eCollection 2022.
5
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.小檗碱防治胃癌:康拉得级联多步作用机制是其治疗作用的基础。
Pharmacol Res. 2022 Oct;184:106440. doi: 10.1016/j.phrs.2022.106440. Epub 2022 Sep 13.
6
Manpixiao Decoction Halted the Malignant Transformation of Precancerous Lesions of Gastric Cancer: From Network Prediction to Verification.慢癖消汤阻断胃癌癌前病变的恶性转化:从网络预测到验证
Front Pharmacol. 2022 Aug 5;13:927731. doi: 10.3389/fphar.2022.927731. eCollection 2022.
7
Effects of on tumor microenvironment and immunotherapy responses.对肿瘤微环境和免疫治疗反应的影响。
Front Immunol. 2022 Jul 28;13:923477. doi: 10.3389/fimmu.2022.923477. eCollection 2022.
8
The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis.质子泵抑制剂对自身免疫性萎缩性胃炎患者胃肿瘤性病变发展的影响。
Front Immunol. 2022 Jul 22;13:910077. doi: 10.3389/fimmu.2022.910077. eCollection 2022.
9
Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis.使用叶酸补充剂来阻止甚至逆转胃癌前病变的进展:一项荟萃分析。
BMC Gastroenterol. 2022 Aug 2;22(1):370. doi: 10.1186/s12876-022-02390-y.
10
Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study.血浆脂质标志着癌前胃部病变向胃癌的进展:一项前瞻性靶向脂质组学研究。
Theranostics. 2022 Jun 6;12(10):4671-4683. doi: 10.7150/thno.74770. eCollection 2022.